Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what the evidential basis is for NHS England's decision not to fund the pre-exposure drug prophyaxis for HIV for the at-risk population.

NHS England has placed its position on the commissioning of pre-exposure prophylaxis (PrEP) under review. This review of the commissioning process will be undertaken by the Specialised Services Committee of NHS England in late May 2016. Depending on the outcome of that decision, a further decision taking account of the clinical evidence for PrEP, the evidence and demand for other new treatments not currently commissioned and NHS England's available funding and priorities is currently planned for June 2016.